Demo Data from EDBT 2026 / reviewers in the wild / expert
Raghunandan Reddy Alugubelli
dblp:327/9422
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2022
—ORCID · unresolved
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 67% Medical and health informatics · 33% |
Topics — the 3 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › bioimage informatics
cell tracking |
0.6 | 1 | 2022 | CancerCellTracker: a brightfield time-lapse microscopy framework for cancer drug sensitivity estimation · Bioinform. 2022 |
Bioinformatics and computational biology › computational pharmacology
drug sensitivity analysis |
0.6 | 1 | 2022 | CancerCellTracker: a brightfield time-lapse microscopy framework for cancer drug sensitivity estimation · Bioinform. 2022 |
Medical and health informatics › precision medicine
precision oncology |
0.6 | 1 | 2022 | CancerCellTracker: a brightfield time-lapse microscopy framework for cancer drug sensitivity estimation · Bioinform. 2022 |
Methods — techniques the papers use, named apart from their topics
time-lapse microscopy · 0.6image processing · 0.6
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2022 | CancerCellTracker: a brightfield time-lapse microscopy framework for cancer drug sensitivity estimationabstractMOTIVATION: Time-lapse microscopy is a powerful technique that relies on images of live cells cultured ex vivo that are captured at regular intervals of time to describe and quantify their behavior under certain experimental conditions. This imaging method has great potential in advancing the field of precision oncology by quantifying the response of cancer cells to various therapies and identifying the most efficacious treatment for a given patient. Digital image processing algorithms developed so far require high-resolution images involving very few cells originating from homogeneous cell line populations. We propose a novel framework that tracks cancer cells to capture their behavior and quantify cell viability to inform clinical decisions in a high-throughput manner. RESULTS: The brightfield microscopy images a large number of patient-derived cells in an ex vivo reconstruction of the tumor microenvironment treated with 31 drugs for up to 6 days. We developed a robust and user-friendly pipeline CancerCellTracker that detects cells in co-culture, tracks these cells across time and identifies cell death events using changes in cell attributes. We validated our computational pipeline by comparing the timing of cell death estimates by CancerCellTracker from brightfield images and a fluorescent channel featuring ethidium homodimer. We benchmarked our results using a state-of-the-art algorithm implemented in ImageJ and previously published in the literature. We highlighted CancerCellTracker's efficiency in estimating the percentage of live cells in the presence of bone marrow stromal cells. AVAILABILITY AND IMPLEMENTATION: https://github.com/compbiolabucf/CancerCellTracker. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Qibing Jiang, Praneeth Sudalagunta, Maria C. Silva, Rafael R. Canevarolo, Xiaohong Zhao, Khandakar Tanvir Ahmed, Raghunandan Reddy Alugubelli, Gabe DeAvila, Alexandre Tungesvik, Lia Perez, Robert A. Gatenby, Robert J. Gillies, Rachid Baz, Mark B. Meads, Kenneth H. Shain, Ariosto Siqueira Silva, Wei Zhang 0076 |
Bioinform. | 7 |